Cover Image
市場調查報告書

韋格納肉芽腫:全球臨床實驗檢討

Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318812
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
韋格納肉芽腫:全球臨床實驗檢討 Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 78 Pages
簡介

本報告提供韋格納肉芽腫的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 韋格納肉芽腫
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上韋格納肉芽腫所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上韋格納肉芽腫所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

韋格納肉芽腫治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Nippon Kayaku Co., Ltd.
    • Zenyaku Kogyo Co., Ltd.
    • Nordic Pharma Group
    • Human Genome Sciences, Inc. (Inactive)
    • Anthera Pharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • Assistance Publique - Hopitaux de Paris
    • University of Pennsylvania
    • Cambridge University Hospitals NHS Foundation Trust
    • University of Oxford
    • National Cancer Institute
    • University Medical Center Groningen
    • University Hospitals Birmingham NHS Foundation Trust
    • Northwestern University
    • Children's Hospital of Eastern Ontario

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2413CTIDB

GlobalData's clinical trial report, "Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014" provides data on the Wegener's Granulomatosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wegener's Granulomatosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wegener's Granulomatosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Wegener's Granulomatosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Wegener's Granulomatosis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Wegener's Granulomatosis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Wegener's Granulomatosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Wegener's Granulomatosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Nippon Kayaku Co., Ltd.
      • Clinical Trial Overview of Nippon Kayaku Co., Ltd.
      • Zenyaku Kogyo Co., Ltd.
      • Clinical Trial Overview of Zenyaku Kogyo Co., Ltd.
      • Nordic Pharma Group
      • Clinical Trial Overview of Nordic Pharma Group
      • Human Genome Sciences, Inc. (Inactive)
      • Clinical Trial Overview of Human Genome Sciences, Inc. (Inactive)
      • Anthera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anthera Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Cambridge University Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University Medical Center Groningen
      • Clinical Trial Overview of University Medical Center Groningen
      • University Hospitals Birmingham NHS Foundation Trust
      • Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Children's Hospital of Eastern Ontario
      • Clinical Trial Overview of Children's Hospital of Eastern Ontario
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Wegener's Granulomatosis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Wegener's Granulomatosis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Wegener's Granulomatosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zenyaku Kogyo Co., Ltd., 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nordic Pharma Group, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Human Genome Sciences, Inc. (Inactive), 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital of Eastern Ontario, 2014*

List of Figures

  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Wegener's Granulomatosis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Wegener's Granulomatosis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Wegener's Granulomatosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Wegener's Granulomatosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Wegener's Granulomatosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top